AMCo comes again for a bolt-on levloan
Amdipharm Mercury, the UK generic pharmaceuticals company also known as AMCo, has laid out price guidance for a €163.7m leveraged loan that will fund a bolt-on acquisition.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: